Actelion Pharmaceuticals Ltd /
Actelion is initiating Phase III clinical development of the novel antibiotic
cadazolid in patients suffering from Clostridium difficile associated diarrhea
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this ...
↧